Literature DB >> 4039229

Studies on vitamin D binding protein in the nephrotic syndrome.

K Colston, N J Williams, H J Cleeve.   

Abstract

We studied the properties of vitamin D binding protein in plasma and urine from nine patients with nephrotic syndrome. Samples were incubated with 25-[3H]hydroxyvitamin D3, after which we determined binding capacity and apparent dissociation constants. Binding capacity was markedly less in plasma from patients with nephrotic syndrome than that from normal subjects, but binding affinity was unchanged. Specific binding of 25-hydroxy[3H]vitamin D3 could be demonstrated in urine from all the nephrotic patients, and sucrose density-gradient analysis of these urines revealed a single binding peak with sedimentation characteristics similar to those of vitamin D binding protein in plasma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4039229

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  10 in total

1.  Hyperphosphatemia is prevalent among children with nephrotic syndrome and normal renal function.

Authors:  Sofia Feinstein; Rachel Becker-Cohen; Choni Rinat; Yaacov Frishberg
Journal:  Pediatr Nephrol       Date:  2006-08-08       Impact factor: 3.714

2.  Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.

Authors:  Amira Shoukry; Shereen El-Arabi Bdeer; Rehab H El-Sokkary
Journal:  Mol Cell Biochem       Date:  2015-06-24       Impact factor: 3.396

3.  Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome.

Authors:  Mustafa Bak; Erkin Serdaroglu; Rengin Guclu
Journal:  Pediatr Nephrol       Date:  2005-12-29       Impact factor: 3.714

4.  Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency?

Authors:  Kathryn M Thrailkill; Chan-Hee Jo; Gael E Cockrell; Cynthia S Moreau; John L Fowlkes
Journal:  J Clin Endocrinol Metab       Date:  2010-10-13       Impact factor: 5.958

Review 5.  Impaired vitamin D metabolism in CKD.

Authors:  Cortney Bosworth; Ian H de Boer
Journal:  Semin Nephrol       Date:  2013-03       Impact factor: 5.299

6.  Vitamin D metabolites in childhood nephrotic syndrome.

Authors:  A Grymonprez; W Proesmans; M Van Dyck; I Jans; G Goos; R Bouillon
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

Review 7.  VITAMIN D BINDING PROTEIN AND 25-HYDROXYVITAMIN D LEVELS: EMERGING CLINICAL APPLICATIONS.

Authors:  Navinder K Jassil; Anupa Sharma; Daniel Bikle; Xiangbing Wang
Journal:  Endocr Pract       Date:  2017-01-17       Impact factor: 3.443

8.  Elevated urinary level of vitamin D-binding protein as a novel biomarker for diabetic nephropathy.

Authors:  Xiao-Qin Tian; Li-Min Zhao; Jia-Pu Ge; Yan Zhang; Yan-Cheng Xu
Journal:  Exp Ther Med       Date:  2013-11-26       Impact factor: 2.447

Review 9.  Vitamin D Binding Protein Impact on 25-Hydroxyvitamin D Levels under Different Physiologic and Pathologic Conditions.

Authors:  Pegah Yousefzadeh; Sue A Shapses; Xiangbing Wang
Journal:  Int J Endocrinol       Date:  2014-04-28       Impact factor: 3.257

10.  Assessment of Vitamin D-Binding Protein and Early Prediction of Nephropathy in Type 2 Saudi Diabetic Patients.

Authors:  Manal S Fawzy; Baraah T Abu AlSel
Journal:  J Diabetes Res       Date:  2018-04-03       Impact factor: 4.011

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.